| Literature DB >> 25527860 |
Mamoru Morimoto, Hidehiko Kitagami, Tetsushi Hayakawa, Moritsugu Tanaka, Yoichi Matsuo1, Hiromitsu Takeyama.
Abstract
BACKGROUND: Laparoscopic procedures are increasingly being applied to gastric cancer surgery, including total gastrectomy for tumors located in the upper gastric body. Even for expert surgeons, esophagojejunostomy after laparoscopy-assisted total gastrectomy (LATG) can be technically challenging. We perform the overlap method of esophagojejunostomy after LATG for gastric cancer. However, technical questions remain. Is the overlap method safer and more useful than other anastomosis techniques, such as methods using a circular stapler? In addition, while we perform this overlap reconstruction after LATG in a deep and narrow operative field, can the overlap method be performed safely regardless of body habitus? This study aimed to evaluate these issues retrospectively and to review the literature.Entities:
Mesh:
Year: 2014 PMID: 25527860 PMCID: PMC4364598 DOI: 10.1186/1477-7819-12-392
Source DB: PubMed Journal: World J Surg Oncol ISSN: 1477-7819 Impact factor: 2.754
Figure 1Placement of trocars. The first trocar is inserted at the umbilicus (1), and used in minilaparotomy. At (3) and (5), a 5-mm trocar is used. At (2) and (4), a 12-mm trocar is used. At (6), a liver retractor is used.
Figure 2Schema of the overlap method. (a) A small opening is made on the left wall of the esophageal stump. (b) An endoscopic linear stapler is applied between the esophageal stump and the jejunal limb. (c) An anastomotic staple line is created between the esophagus and jejunum. (d) The entry hole is closed using an intracorporeal interrupted hand-sewn technique.
Clinical characteristics
| Age (years) | 66.2 ± 12.2 (34 to 89) | |
| Sex (male: female) | 61:16 | |
| Body mass index (kg/m2) | 22.4 ± 2.9 (16.5 to 29.3) | |
| American Society of Anesthesiology | 1 | 17 (22%) |
| 2 | 60 (78%) | |
| Concurrent illness* | No | 40 (52%) |
| Yes | 37 (48%) | |
| Cardiovascular disease | 23 | |
| Diabetes mellitus | 4 | |
| Respiratory disease | 2 | |
| Liver disease | 1 | |
| Other operation | 13 | |
| Brain disorder | 3 | |
| Extent of lymph-node dissection | ||
| D1+ | 49 (64%) | |
| D2 | 28 (36%) | |
*Some patients had more than one comorbidity.
Operative and postoperative data
| Operation time (min) | 391.4 ± 51.3 (280 to 495) | ||
| Time to perform anastomosis (min) | 36.3 ± 6.8 (24 to 52) | ||
| Estimated blood loss (ml) | 146.9 ± 129.5 (3 to 510) | ||
| Transfusion | 1 (1%) | ||
| Conversion to open surgery | 0 | ||
| Number of harvested lymph nodes | 40.5 ± 13.7 (16 to 83) | ||
| D1+ | 38 ± 12.7 (16 to 65) | ||
| D2 | 42 ± 14.1 (17 to 83) | ||
| Combined resection | Spleen | 23 (30%) | |
| Gall bladder | 4 (5%) | ||
| Time until start of oral intake (days) | 3.9 ± 2.1 (2 to 17) | ||
| Time to first flatus (days) | 2.3 ± 0.9 (1 to 4) | ||
| Postoperative hospital stay (days) | 13.4 ± 5.8 (7 to 96) | ||
| Complications | No | 68 (88%) | |
| Yes | 10 (13%) | ||
| Complications related to anastomosis | 1 (1%) | ||
| Leakage | 0 | ||
| Bleeding | 0 | ||
| Stenosis | 1 (1%) | Grade I* | |
| Pancreatitis | 4 (5%) | ||
| Intra-abdominal bleeding | 2 (3%) | Grade IIIb* | |
| Duodenal stump leakage | 2 (3%) | Grade IIIa* | |
| Intra-abdominal abscess | 1 (1%) | Grade IIIa* | |
*According to the Clavien-Dindo classification of surgical complications.
Pathological findings
| Histological type | |
| Well differentiated | 12 (16%) |
| Moderately differentiated | 27 (35%) |
| Poorly differentiated | 31 (40%) |
| Signet ring cell | 4 (5%) |
| Other (med, pap) | 3 (4%) |
| Proximal resected margin (mm) | 21.1 ± 9.7 (10 to 35) |
| Stage* | |
| IA | 30 (39%) |
| IB | 11 (14%) |
| IIA | 12 (16%) |
| IIB | 6 (8%) |
| IIIA | 9 (12%) |
| IIIB | 9 (12%) |
*According to the Japanese Classification of Gastric Carcinoma: 3rd English Edition.
Surgical outcomes (BMI: 22 kg/m )
| Group A ( | Group B ( |
| ||
|---|---|---|---|---|
| Operation time (min) | 392.8 ± 55.1 (280 to 495) | 389.2 ± 45.7 (285 to 464) | — | |
| Time to perform anastomosis (min) | 37.0 ± 7.7 (24 to 52) | 35.4 ± 5.6 (28 to 44) | — | |
| Estimated blood loss (ml) | 156.0 ± 138.8 (5 to 510) | 133.2 ± 115.1 (10 to 360) | — | |
| Complications | No | 41 (87%) | 26 (87%) | — |
| Yes | 6 (13%) | 4 (13%) | — | |
| Complications related to ansastomosis | 0 | 1 (3%) | — | |
| Leakage | 0 | 0 | — | |
| Bleeding | 0 | 0 | — | |
| Stenosis | 0 | 1 (3%) Grade I* | — | |
| Pancreatitis | 2 (4%) | 2 (7%) | — | |
| Intra-abdominal bleeding | 2 (4%) Grade IIIb* | 0 | — | |
| Duodenal stump leakage | 2 (4%) Grade IIIa* | 0 | — | |
| Intra-abdominal abscess | 0 | 1 (3%) Grade IIIa* | — | |
*According to the Clavien-Dindo classification of surgical complications. —, not significant.
Previous reports of intracorporeal anastomosis using circular stapler in LATG
| Reference | Year | Number of patients | Body mass index (kg/m 2) | Mortality | Operation time (min) | Time to perform anastomosis (min) | Blood loss (ml) | Hospitalization (days) | Complications | Anastomotic stenosis | Anastomotic leakage |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||||
| [ | 2005 | 8 | — | 0% | — | — | — | — | — | — | 12.5% |
| [ | 2005 | 8 | — | 0% | 183 | — | 81 | 16.9 | 13% | 0% | 0% |
| [ | 2005 | 10 | — | 0% | — | — | — | — | 10% | 0% | 10% |
| [ | 2006 | 63 | — | — | — | — | — | — | — | 0% | 4.8% |
| [ | 2008 | 27 | 22.6 | 0% | 527.5 | — | — | 16.2 | 7% | — | 0% |
| [ | 2008 | 20 | — | 0% | 254 | — | 299 | 19 | 25% | 5% | 10% |
| [ | 2008 | 38 | 24.0 | 2.6% | 187 | — | 10 | — | 39% | — | 5.3% |
| [ | 2008 | 23 | 23.4 | 0% | 305.9 | — | 77.5 | 11.2 | 4% | 0% | 0% |
| [ | 2009 | 16 | — | 6.3% | 225 | — | — | 16 | — | 0% | 6.3% |
| [ | 2009 | 67 | 22.9 | 0% | 305.4 | — | 190.7 | 13.6 | 27% | 9% | 1.5% |
| [ | 2010 | 10 | 22.4 | 0% | 257 | — | 69 | 13 | 10% | 0% | 0% |
| [ | 2013 | 100 | — | 0% | 249 | — | 182 | — | 18% | — | 6% |
|
| |||||||||||
| [ | 2009 | 16 | 23.0 | 0% | 194 | — | 272 | 11 | 6% | 0% | 0% |
| [ | 2010 | 27 | 24.0 | 0% | — | — | — | — | 4% | 3.8% | 0% |
| [ | 2011 | 30 | 23.0 | 3.3% | 209.8 | 64.5 | 111 | 21.9 | 7% | — | 3.3% |
| [ | 2011 | 16 | 24.9 | 0% | — | — | — | — | 44% | 18.8% | 0% |
| [ | 2012 | 13 | — | 8.6% | — | — | — | — | 15% | 7.5% | 0% |
| [ | 2013 | 12 | 24.3 | 0% | 226.5 | 42.8 | — | 8.4 | — | 33.3% | 16.7% |
| [ | 2013 | 16 | — | 0% | — | — | — | — | 25% | — | 0% |
| [ | 2013 | 40 | 24.0 | 0% | 220.2 | 18.6 | — | 11.6 | — | 3% | 5% |
| [ | 2013 | 21 | 21.2 | 0% | 198 | — | 130 | 12.5 | — | 5% | 5% |
| [ | 2013 | 28 | — | 0% | 143 | — | 70 | 9.6 | 7% | 0% | — |
| [ | 2013 | 17 | 27.1 | 2% | — | — | — | — | 31% | 5.9% | 5.9% |
| [ | 2013 | 52 | 22.8 | 0% | — | — | — | — | — | 21% | 1.9% |
—,not recorded.
Previous reports of intracorporeal anastomosis using linear stapler in LATG
| Authors | Year | Number of patients | Body mass index (kg/m 2) | Mortality | Operation time (min) | Time to perform anastomosis (min) | Blood loss (ml) | Hospitalization (days) | Complications | Anastomotic stenosis | Anastomotic leakage |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||||
| [ | 1999 | 2 | — | 0% | 595 | — | 367.5 | 29.5 | — | 0% | 0% |
| [ | 2002 | 3 | — | 33% | — | — | — | — | 33% | 0% | 0% |
| [ | 2008 | 4 | — | 0% | 381 | 86 | 313 | 11 | 0% | 0% | 0% |
| [ | 2008 | 14 | — | 0% | 255.1 | 42.5 | 107.5 | — | — | 0% | 0% |
| [ | 2009 | 15 | 20.8 | 0% | 325 | — | 195 | 11 | 13% | 0% | 0% |
| [ | 2009 | 55 | — | 0% | 406 | — | 102 | 17 | 33 | — | 3.6% |
| [ | 2010 | 56 | — | 1.5% | 249 | 44 | — | 12.4 | 29% | 3% | 6% |
| [ | 2012 | 27 | 24.6 | 0% | 126 | — | — | 8.1 | 11% | 0% | 0% |
| [ | 2013 | 65 | 23.5 | 1.5% | 271.5 | — | 85.2 | 21.4 | 15.4% | 4.6% | 0% |
|
| |||||||||||
| [ | 2010 | 53 | 22.0 | 0% | 373.4 | — | 146.5 | 14.4 | 24.5% | 0% | 3.8% |
| [ | 2012 | 15 | 21.7 | 0% | 236.4 | — | 51.2 | 13.5 | 16% | 0% | 0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
—, not recorded.